Open Access
ARTICLE
Wei-Zhen Liu, Nian Liu
Oncology Research, Vol.27, No.1, pp. 1-8, 2019, DOI:10.3727/096504018X15172738893959
Abstract Propofol has been widely used in lung cancer resections. Some studies have demonstrated that the effects
of propofol might be mediated by microRNAs (miRNAs). This study aimed to investigate the effects and
mechanisms of propofol on lung cancer cells by regulation of miR-1284. A549 cells were treated with different
concentrations of propofol, while transfected with miR-1284 inhibitor, si-FOXM1, and their negative controls.
Cell viability, migration, and invasion, and the expression of miR-1284, FOXM1, and epithelial–mesenchymal
transition (EMT) factors were detected by CCK-8, Transwell, qRT-PCR, and Western blot assays, respectively.
In addition, the regulatory and binding relationships among propofol, miR-1284, and… More >
Open Access
ARTICLE WITHDRAWN
Li Dong1, Tian Bo2, Jin Xiaosheng3
Oncology Research, Vol.27, No.1, pp. 9-17, 2019, DOI:10.3727/096504018X15178732625479
Abstract THIS ARTICLE WAS WITHDRAWN BY THE PUBLISHERS IN OCTOBER 2020. More >
Open Access
ARTICLE
Lihua Jiang*1,
Wenchuan Yang*1,
Weishi Bian†, Hailin Yang*, Xia Wu*, Yuhua Li*,
Wen Feng*, Xuejian Liu*
Oncology Research, Vol.27, No.1, pp. 19-27, 2019, DOI:10.3727/096504018X15193469240508
Abstract The dysregulation of microRNAs (miRNAs) plays an important function in the onset and progression of gastric
cancer (GC). In addition, aberrantly expressed miRNAs affect the chemosensitivity of GC cells to chemotherapeutic drugs. Hence, miRNA-based targeted therapy might be applied to treat patients with GC exhibiting chemotherapeutic resistance. In this study, miRNA-623 (miR-623) expression was downregulated in GC tissues
and cell lines. Functional analysis showed that the restored miR-623 expression could inhibit the proliferation
of GC cells and enhance their chemosensitivity to 5-FU via the cell apoptosis pathway. Cyclin D1 (CCND1)
was identified as a direct target gene of miR-623 in… More >
Open Access
ARTICLE
Hai Liu*, Xuanxuan Wang*, Aihua Huang†, Huaping Gao‡, Yikan Sun§, Tingting Jiang*,
Liming Shi*, Xianjie Wu¶, Qinghua Dong#, Xiaonan Sun*
Oncology Research, Vol.27, No.1, pp. 29-38, 2019, DOI:10.3727/096504018X15179694020751
Abstract Artemis is a key protein of NHEJ (nonhomologous end joining), which is the major pathway for the repair
of IR-induced DSBs in mammalian cells. However, the expression of Artemis in tumors and the influence of
silencing Artemis on tumor sensitivity to radiation have not been investigated fully. In this study, we investigated how the expression levels of Artemis may affect the treatment outcome of radiotherapy and chemotherapy in colorectal cancer cells. First, we found that the expression of Artemis is strong in some human rectal
cancer samples, being higher than in adjacent normal tissues using immunohistochemical staining. We then
knocked… More >
Open Access
ARTICLE
Zhenjun Liu*, Pei Zhao*, Yuping Han†, Song Lu*
Oncology Research, Vol.27, No.1, pp. 39-45, 2019, DOI:10.3727/096504018X15199482824130
Abstract Long noncoding RNAs (lncRNAs) have been reported to play important roles in tumorigenesis. In the present study, we demonstrated that lncRNA forebrain embryonic zinc finger protein 1 (FEZF1) antisense RNA1
(FEZF1-AS1) is markedly upregulated in human lung adenocarcinoma (LAD) tissues and cell lines and is
associated with poor prognosis. Loss of function revealed that deletion of FEZF1-AS1 expression significantly
inhibited the LAD cell proliferation, invasion, and migration. Further studies revealed that downregulation of
FEZF1-AS1 reduced mRNA and protein expression of its sense-cognate gene FEZF1 in LAD cells, and vice
versa. Correlation analysis indicated that there was a positive correlation between… More >
Open Access
ARTICLE
Jia Yu, Qiyu Fang, Shuyan Meng
Oncology Research, Vol.27, No.1, pp. 47-53, 2019, DOI:10.3727/096504018X15193843443255
Abstract Non-small cell lung cancer (NSCLC) represents the leading cause of cancer-related mortality worldwide. More
and more reports have identified important roles for long noncoding RNAs (lncRNAs) in cancer development.
ENST457720 expression was upregulated in lung adenocarcinoma in a microarray-based lncRNA screen. We
determined the expression levels of ENST457720 in NSCLC tissues with quantitative real-time PCR and then
studied their clinical significance. We explored the biological significance of ENST457720 with gain- and lossof-function analyses in vitro and in vivo. In this study, ENST457720 was expressed at higher levels in NSCLC
tissues than in paired normal tissues. Higher ENST457720 expression was associated… More >
Open Access
ARTICLE
Genglong Zhu*, Xialei Liu*, Yonghui Su†, Fangen Kong‡, Xiaopeng Hong*, Zhidong Lin†
Oncology Research, Vol.27, No.1, pp. 55-64, 2019, DOI:10.3727/096504018X15201143705855
Abstract Liver cancer is one of the most common malignancies in the world and a leading cause of cancer-related mortality. Accumulating evidence has highlighted the critical role of long noncoding RNAs (lncRNAs) in various
cancers. The present study aimed to explore the role of lncRNA urothelial carcinoma-associated 1 (UCA1) in
cell growth and migration in MHCC97 cells and its underlying mechanism. First, we assessed the expression
of UCA1 in MHCC97 and three other cell lines by RT-qPCR. Then the expression of UCA1, miR-301a, and
CXCR4 in MHCC97 cells was altered by transient transfection. The effects of UCA1 and miR-301 on cell… More >
Open Access
ARTICLE
Yuping Peng, Xuning Shen, Honggang Jiang, Zhiheng Chen, Jiaming Wu, Yi Zhu, Yuan Zhou, Jin Li
Oncology Research, Vol.27, No.1, pp. 65-71, 2019, DOI:10.3727/096504018X15191223015016
Abstract MicroRNAs (miRNAs) have been demonstrated to be essential regulators in the development and progression
of various cancers. The role of miR-188-5p in gastric cancer (GC) has not been determined. In this study, we
found that the expression of miR-188-5p was downregulated in GC tissues compared with adjacent normal tissues. The lowly expressed miR-188-5p was significantly associated with lymph node metastasis and advanced
TNM stage. Moreover, overexpression of miR-188-5p significantly inhibited GC cell proliferation, migration,
and invasion but promoted cellular apoptosis. Mechanistically, we identified transcription factor ZFP91 as a
target gene of miR-188-5p in GC. We found that miR-188-5p overexpression significantly… More >
Open Access
ARTICLE
Xiaohui Shen, Xia Gao, Hui Li, Yajun Gu, Junguo Wang
Oncology Research, Vol.27, No.1, pp. 73-80, 2019, DOI:10.3727/096504018X15201099883047
Abstract Laryngeal carcinoma is a type of head and neck carcinoma with a high incidence and mortality. Chemotherapy
treatments of human laryngeal carcinoma may fail due to the development of chemoresistance. Tissue inhibitor
of metalloproteinase 3 (TIMP-3) has been shown to be implicated in a number of pathological processes typical
for cancer. The present study aims to investigate the involvement of TIMP-3 in the chemoresistance of laryngeal
carcinoma. We showed that TIMP-3 expression was significantly decreased in chemoresistant laryngeal carcinoma tissues compared with chemosensitivity tissues. Patients with low TIMP-3 expression exhibited poorer
overall survival than those with high TIMP-3 expression. Moreover,… More >
Open Access
ARTICLE
Jinfeng Qu*, Lei Zhang†, Lanyu Li*, Yujie Su*
Oncology Research, Vol.27, No.1, pp. 81-88, 2019, DOI:10.3727/096504018X15202988139874
Abstract This study investigated the tumor-suppressive role of miR-148b in regulating endoplasmic reticulum metalloprotease 1 (ERMP1) expression and the oxidative stress response in endometrial cancer cells. Human endometrial cancer RL95-2 cells were used and transfected with miR-148b mimic, miR-148b inhibitor, or their
scrambled negative control. Thereafter, the transfection efficiency was determined by RT-qPCR, and cell proliferation was assessed by MTT assay. The dual-luciferase reporter assay, Western blot, and RT-qPCR were
conducted to determine the target gene of miR-148b. ERMP1 is a putative target of miR-148b, and thereby the
overexpression and downregulation of ERMP1 on the proliferation of RL95-2 cells were assessed.… More >
Open Access
ARTICLE
Bo Xia*, Lei Wang†, Li Feng*, Baofang Tian*, Yuanjie Tan‡, Baoyin Du*
Oncology Research, Vol.27, No.1, pp. 89-98, 2019, DOI:10.3727/096504018X15199511344806
Abstract Osteosarcoma is the most common primary malignant bone tumor in children and adolescents. This study
aimed to explore the effects of long noncoding RNA CAT104 and microRNA-381 (miR-381) on osteosarcoma
cell proliferation, migration, invasion, and apoptosis, as well as the underlying potential mechanism. We found
that CAT104 was highly expressed in osteosarcoma MG63 and OS-732 cells. Knockdown of CAT104 significantly inhibited OS-732 cell proliferation, migration, and invasion, but promoted cell apoptosis. CAT104
regulated the expression of miR-381, and miR-381 participated in the effects of CAT104 on OS-732 cells. Zinc
finger E-box-binding homeobox 1 (ZEB1) was a direct target gene of… More >
Open Access
ARTICLE
Xingxiang Liu*†, Lin Cui†, Dong Hua*‡
Oncology Research, Vol.27, No.1, pp. 99-106, 2019, DOI:10.3727/096504018X15195193936573
Abstract We aimed to investigate the significant role of long noncoding RNA X inactive specific transcript (XIST)
in regulating tumor metastasis in colorectal cancer (CRC), as well as its possible mechanism. Expression of
lncRNA XIST in CRC tissues and CRC cells was detected. CRC cells were transfected with pc-XIST, blank
control si-XIST, or si-control, and then the effects of lncRNA XIST on CRC cell migration and invasion were
investigated, along with the interaction between lncRNA XIST and miR-137. lncRNA XIST was upregulated
in CRC tissues. Compared with HT29 cells that had low metastatic potential, XIST was markedly more highly
expressed in… More >
Open Access
ARTICLE WITHDRAWN
Dai Jinhua1, Ma Jianbo1, Yu Bixia2, Zhu Zhankun1, Hu Yanqin2
Oncology Research, Vol.27, No.1, pp. 107-115, 2019, DOI:10.3727/096504018X15205622257163
Abstract THIS ARTICLE WAS WITHDRAWN BY THE PUBLISHERS IN OCTOBER 2020. More >
Open Access
ARTICLE
Yang Cao*, Xu Shi†, Yingmin Liu‡, Ren Xu§, Qing Ai*
Oncology Research, Vol.27, No.1, pp. 117-124, 2019, DOI:10.3727/096504018X15213031799835
Abstract MicroRNA-338-3p (miR-338-3p) has been reported to be a tumor suppressor in multiple cancer types.
However, the biological role of miR-338-3p and its underlying mechanism in multiple myeloma (MM)
remain unclear. In the present study, we investigated the biological role and potential of miR-338-3p in
MM. We found that miR-338-3p was significantly decreased in newly diagnosed and relapsed MM tissues and cell lines. Overexpression of miR-338-3p in MM cells significantly inhibited proliferation and
promoted apoptosis, caspase 3, and caspase 8 activity. Bioinformatics algorithm analysis predicted that
cyclin-dependent kinase 4 (CDK4) was a direct target of miR-338-3p, and this was experimentally verified… More >
Open Access
ARTICLE
Gang Li*, Tie Chong*, Jie Yang†, Hongliang Li*, Haiwen Chen*
Oncology Research, Vol.27, No.1, pp. 125-137, 2019, DOI:10.3727/096504018X15213115046567
Abstract KIFC1 (kinesin family member C1) plays a critical role in clustering of extra centrosomes in various cancer
cells and thus could be considered as a promising therapeutic target. However, whether KIFC1 is involved
in the procession of renal cell carcinoma (RCC) still remains unclear. In this study, we found that KIFC1 was
upregulated in RCC tissues and is responsible for RCC tumorigenesis (p<0.001). The high expression of
KIFC1 correlates with aggressive clinicopathologic parameters. Kaplan–Meier analysis suggested that KIFC1
was associated with poor survival prognosis in RCC. Silencing KIFC1 dramatically resulted in inhibition of
proliferation, delayed the cell cycle at G2/M… More >
Login
Register
Submit a Paper
Propose a Special lssue